Lycopene / IL1β Cancer Research Results

Lyco, Lycopene: Click to Expand ⟱
Features:
Lycopene is a naturally occurring carotenoid found predominantly in tomatoes and other red fruits and vegetables.

Antioxidant Properties:
-Lycopene is a powerful antioxidant. It helps neutralize free radicals, which can reduce oxidative stress—a factor implicated in cancer development. Possible concern about interfering with chemotherapy and radiation therapy. However this review disagrees.
Inflammation Reduction:
-Some studies suggest that lycopene may help lower levels of inflammation, another process linked to cancer progression

At supraphysiological or extremely high concentrations, lycopene may have the potential to switch from an antioxidant to a prooxidant role
-The prooxidant effect of lycopene has been observed under conditions of high oxygen tension. In vitro studies have suggested that in environments with elevated oxygen levels, lycopene might promote rather than neutralize the production of reactive oxygen species (ROS).
-The presence of metal ions (such as iron or copper) in the environment can catalyze reactions where antioxidants, including lycopene, contribute to oxidative processes. These metals can interact with lycopene, potentially leading to the formation of radicals.

The mevalonate pathway produces cholesterol and a variety of isoprenoids, which are important for maintaining cell membrane integrity, protein prenylation, and other essential cellular functions.
-One of the primary enzymes in this pathway is HMG-CoA reductase (3-hydroxy-3-methylglutaryl-coenzyme A reductase), which is the target of statin drugs used for lowering cholesterol. Some studies suggest that lycopene might downregulate the activity of HMG-CoA reductase or other enzymes in the mevalonate pathway. By doing so, lycopene could potentially reduce the synthesis of cholesterol and isoprenoids that are necessary for rapid cell proliferation—an especially relevant aspect in cancer cells.

Lycopene typically used in a 100mg/day range for cancer (inhibition of the the Melavonate Pathway)
-also has antiplatelet aggregation capability.

-Note half-life 16–20 days.
BioAv Heat processing, especially when combined with a small amount of fat, significantly enhances lycopene’s bioaccessibility and absorption. (20% under optimal conditions)
Pathways:
- ROS usually goes down, but may go up or down depending on dose and environment. Lycopene may also be modified to be a "oxdiative product" which may change the behaviour.
- Raises AntiOxidant defense in Normal Cells: ROS↓, NRF2↑, SOD↑, GSH↑, Catalase↑,
- lowers Inflammation : NF-kB↓, COX2↓, p38↓, Pro-Inflammatory Cytokines : NLRP3↓, IL-1β↓, TNF-α↓, IL-6↓, IL-8↓
- inhibit Growth/Metastases : EMT↓, MMPs↓, MMP9↓, IGF-1↓, uPA↓, VEGF↓, ROCK1↓, FAK↓, RhoA↓, NF-κB↓, ERK↓
- reactivate genes thereby inhibiting cancer cell growth : EZH2↓, P53↑, Sp proteins↓,
- cause Cell cycle arrest : TumCCA↑, cyclin D1↓, cyclin E↓, CDK2↓, CDK4↓,
- inhibits Migration/Invasion : TumCMig↓, TumCI↓, TNF-α↓, FAK↓, ERK↓, EMT↓,
- inhibits angiogenesis↓ : VEGF↓, HIF-1α↓, Integrins↓,
- Others: PI3K↓, AKT↓, JAK↓, STAT↓, Wnt↓, β-catenin↓, AMPK, ERK↓, JNK, - SREBP (related to cholesterol).
- Synergies: chemo-sensitization, chemoProtective, RadioSensitizer, RadioProtective, Others(review target notes), Neuroprotective, Cognitive, Renoprotection, Hepatoprotective, CardioProtective,

- Selectivity: Cancer Cells vs Normal Cells

Rank Pathway / Axis Cancer Cells Normal Cells Label Primary Interpretation Notes
1 Reactive oxygen species (ROS) ↓ ROS ↓ ROS Driver Potent antioxidant activity Lycopene is a strong singlet-oxygen quencher with antioxidant dominance
2 IGF-1 / PI3K → AKT signaling ↓ IGF-1 signaling; ↓ AKT ↔ minimal Secondary Growth factor signaling attenuation Reduced IGF-1–driven proliferation is a key cancer-relevant effect
3 Cell cycle regulation ↑ G0/G1 arrest ↔ spared Phenotypic Cytostatic growth control Cell-cycle effects reflect growth factor modulation
4 Gap junction communication (connexins) ↑ gap junction signaling ↑ gap junction signaling Secondary Normalization of cell–cell communication Enhanced gap junctions are associated with reduced tumor progression
5 NF-κB / inflammatory signaling ↓ inflammatory signaling ↓ inflammatory tone Secondary Anti-inflammatory environment Inflammation reduction contributes to chemopreventive effects


IL1β, interleukin-1 beta: Click to Expand ⟱
Source:
Type:
The term "IL-1" is often used as an umbrella term for the interleukin-1 family, which includes multiple cytokines. The two best-known members are IL-1α and IL-1β.
IL-1β is secreted from cells and plays a major systemic role in inflammation. It is a crucial mediator in the inflammatory response and is involved in the fever response, activation of endothelial cells, and leukocyte recruitment.
Its increased expression is commonly linked to:
  – Promotion of a pro-inflammatory microenvironment that supports tumor growth.
  – Enhanced angiogenesis, invasion, and metastasis.
  – Recruitment of myeloid cells that may further suppress antitumor immunity.

High expression of either tends to be associated with a more aggressive phenotype and worse prognosis in many cancer types.


Scientific Papers found: Click to Expand⟱
4782- Lyco,    New Insights into Molecular Mechanism behind Anti-Cancer Activities of Lycopene
- Review, Var, NA
"highlight2" >AntiCan↑, From an anti-cancer perspective, lycopene is often associated with reduced risk of prostate cancer and people often look for it as a dietary supplement which may help to prevent cancer.
"highlight2" >TumCP↓, Lycopene was known to be able to suppress cancerous cell proliferation, migration, invasion and adhesion activity in cell culture studies.
"highlight2" >TumCMig↓,
"highlight2" >TumCI↓,
"highlight2" >TumCA↓,
"highlight2" >ROS↓, Such suppression was often observed with changes of cancer-related gene expression and relief of oxidative stress
"highlight2" >MMP2↓, In general, lycopene could suppress the expression of MMP-2, MMP-7, MMP-9, Sp1, IGF-1R, VEGF while increasing E-cadherin stabilization, connexin 43, nm23-H1, TIMP-1 and TIMP-2 levels
"highlight2" >MMP7↓,
"highlight2" >MMP9↓,
"highlight2" >VEGF↓,
"highlight2" >E-cadherin↑,
"highlight2" >TIMP1↑,
"highlight2" >TIMP2↑,
"highlight2" >BioAv↝, it is recommended to avoid consumption of lycopene concurrently with high dietary fiber intake as several types of dietary fiber were found to be able to reduce the bioavailability of lycopene
"highlight2" >*IL12↓, lycopene could suppress proinflammatory cytokines such as IL-12, TNF-α, IL-1, IL-1β, IL-6
"highlight2" >*TNF-α↓,
"highlight2" >*IL1↓,
"highlight3" >*IL1β↓,
"highlight2" >*IL6↓,
"highlight2" >COX2↓, Sprague Dawley rat model, lycopene treatment after induction by azoxymethane caused suppression of aberrant crypt foci, preneoplastic lesion and biomarkers such as COX-2 and iNOS expression
"highlight2" >iNOS↓,
"highlight2" >*radioP↑, lycopene before induction of DNA damage via X-irradiation as lycopene treatment after irradiation failed to show such DNA protective effect
"highlight2" >NF-kB↓, anti-cancer effect of lycopene was also observed in pancreatic cancer cells (PANC-1 cell line) whereby significant reduction of ROS, NF-κB and anti-apoptotic biomarkers (cIAP1, cIAP2 and survivin) was detected while an increment of caspase-3 and Bax:
"highlight2" >survivin↓,
"highlight2" >Casp3↑,
"highlight2" >Bax:Bcl2↑,

4781- Lyco,  5-FU,  Chemo,  Cisplatin,    Antioxidant and anti-inflammatory activities of lycopene against 5-fluorouracil-induced cytotoxicity in Caco2 cells
- in-vitro, Colon, Caco-2
"highlight2" >chemoP↑, One such useful natural antioxidant that has been widely investigated to suppress chemotherapy induced side effects of drugs such as cisplatin is lycopene
"highlight2" >Inflam↓, lycopene was found to significantly suppress inflammatory responses in CC cells by inhibiting pro-inflammatory cytokines expression like cyclooxygenase-2 (COX-2), interleukin 1β (IL-1β), IL-6 and tumor necrosis-α (TNF-α)
"highlight2" >COX2↓,
"highlight3" >IL1β↓,
"highlight2" >IL6↓,
"highlight2" >TNF-α↓,
"highlight2" >ROS↑, Our results indicated the cells treatment with 60 µg/ml lycopene significantly increased ROS generation
"highlight2" >ChemoSen↑, Furthermore, L60 and L120 seemed to enhance 5FU-induced ROS generation
"highlight2" >SOD↓, significant increase SOD activity

4230- Lyco,    Supplementation of lycopene attenuates oxidative stress induced neuroinflammation and cognitive impairment via Nrf2/NF-κB transcriptional pathway
- in-vivo, AD, NA
"highlight2" >*BDNF↑, LYC ameliorated histopathological damage and restored brain derived neurotrophic factor (BDNF) levels in the hippocampus of mice.
"highlight2" >*antiOx↑, LYC also significantly elevated antioxidant enzymes activities and reduced levels of inflammatory cytokines in the d-galactose-treated mice serum.
"highlight2" >*Inflam↓,
"highlight2" >*HO-1↑, LYC treatment activated the mRNA expressions of antioxidant enzymes HO-1 and NQO-1, and downregulated inflammatory cytokines IL-1β and TNF-α
"highlight2" >*NQO1↑,
"highlight3" >*IL1β↓,
"highlight2" >*TNF-α↓,
"highlight2" >*ROS↓, LYC attenuated neuronal oxidative damage through activation of Nrf2 signaling
"highlight2" >*NRF2↑,
"highlight2" >*cognitive↑, LYC could ameliorate oxidative stress induced neuroinflammation and cognitive impairment possibly via mediating Nrf2/NF-κB transcriptional pathway.
"highlight2" >*BBB↑, LYC exerts antioxidant and anti-inflammatory effects both in vitro and in vivo and possesses blood brain barrier permeability

3528- Lyco,    The Importance of Antioxidant Activity for the Health-Promoting Effect of Lycopene
- Review, Nor, NA - Review, AD, NA - Review, Park, NA
"highlight2" >*antiOx↑, the antioxidant effect of lycopene
"highlight2" >*ROS↓, Lycopene has the ability to reduce reactive oxygen species (ROS) and eliminate singlet oxygen, nitrogen dioxide, hydroxyl radicals, and hydrogen peroxide
"highlight2" >*BioAv↝, human body cannot synthesize lycopene. It must be supplied with the diet
"highlight2" >*Half-Life↑, half-life of lycopene in human plasma is 12–33 days
"highlight2" >*BioAv↓, bioavailability decreases with age and in the case of certain diseases
"highlight2" >*BioAv↑, heat treatment process of food increases the bioavailability of lycopene
"highlight2" >*cardioP↑, positive effect on cardiovascular diseases, including the regulation of blood lipid levels
"highlight2" >*neuroP↑, beneficial effects in nervous system disorders, including neurodegenerative diseases such as Parkinson′s disease and Alzheimer′s disease
"highlight2" >*H2O2↓, Lycopene has the ability to reduce reactive oxygen species (ROS) and eliminate singlet oxygen, nitrogen dioxide, hydroxyl radicals, and hydrogen peroxide
"highlight2" >*VitC↑, ability to regenerate non-enzymatic antioxidants such as vitamin C and E.
"highlight2" >*VitE↑,
"highlight2" >*GPx↑, increase in cardiac GSH-Px activity and an increase in cardiac GSH levels
"highlight2" >*GSH↑,
"highlight2" >*MPO↓, also a decrease in the level of cardiac myeloperoxidase (MPO), cardiac H2O2, and a decrease in cardiac glutathione S transferase (GSH-ST) activity.
"highlight2" >*GSTs↓,
"highlight2" >*SOD↑, increasing the activity of GSH-Px and SOD in the liver
"highlight2" >*NF-kB↓, reducing the expression of NF-κB mRNA in the heart
"highlight3" >*IL1β↓, decreased the level of IL-1β and IL-6 and increased the level of anti-inflammatory IL-10 in the heart
"highlight2" >*IL6↓,
"highlight2" >*IL10↑,
"highlight2" >*MAPK↓, inhibited the activation of the ROS-dependent pro-hypertrophic mitogen-activated protein kinase (MAPK) and protein kinase B (Akt) signaling pathways.
"highlight2" >*Akt↓,
"highlight2" >*COX2↓, decrease in the levels of pro-inflammatory mediators in heart: COX-2, TNF-α, IL-6, and IL-1β and an increase in the anti-inflammatory cardiac TGF-β1.
"highlight2" >*TNF-α↓,
"highlight2" >*TGF-β1↑,
"highlight2" >*NO↓, reduced NO levels in heart and cardiac NOS activity
"highlight2" >*GSR↑, increase in the level of cardiac and hepatic SOD, CAT, GSH, GPx, and glutathione reductase (GR)
"highlight2" >*NRF2↑, It also activated nuclear factor-erythroid 2 related factor 2 (Nrf2). This affected the downstream expression of HO-1 [97].
"highlight2" >*HO-1↑,
"highlight2" >*TAC↑, Researchers observed an increase in the liver in TAC and GSH levels and an increase in GSH-Px and SOD activity
"highlight2" >*Inflam↓, study showed that lycopene was anti-inflammatory
"highlight2" >*BBB↑, Lycopene is a lipophilic compound, which makes it easier to penetrate the blood–brain barrier.
"highlight2" >*neuroP↑, Lycopene had also a neuroprotective effect by restoring the balance of the NF-κB/Nrf2 pathway.
"highlight2" >*memory↑, lycopene on LPS-induced neuroinflammation and oxidative stress in C57BL/6J mice. The tested carotenoid prevented memory loss

4801- Lyco,    Lycopene in the Prevention of Cardiovascular Diseases
- Review, CardioV, NA
"highlight2" >*BioAv↝, Taking into account the fact that humans are not able to synthesize lycopene de novo, therefore its supply with food is necessary to take advantage of its pro-health properties.
"highlight2" >*cardioP↑, protective effect on cardiovascular diseases
"highlight2" >*BioAv↑, It is assumed that thanks to the cis form, lycopene is highly bioavailable in the human diet
"highlight2" >*BioAv↑, bioavailability of lycopene as a result of its trans to cis isomerization can be achieved by adding fish oil or olive oil to tomato dishes.
"highlight2" >*antiOx↑, Antioxidant Effects of Lycopene
"highlight2" >*ROS↓, Lycopene is a highly effective antioxidant that, due to the high reactivity between the long polyene chain and free radicals, enables the elimination of singlet oxygen and the reduction of reactive oxygen species (ROS)
"highlight2" >*ARE↑, activating the antioxidant response element (ARE)
"highlight2" >*SOD↑, it increases the amount of antioxidant enzymes, which include superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GSH-Px)
"highlight2" >*Catalase↑,
"highlight2" >*GPx↑,
"highlight2" >*lipid-P↓, figure 3
"highlight2" >*COX2↓, lycopene (in the form of watermelon powder) reduced inflammation by reducing the activity of the pro-inflammatory mediator cyclooxygenase 2 (COX-2),
"highlight2" >*Inflam↓, Anti-Inflammatory Mechanism of Lycopene
"highlight3" >*IL1β↓, inhibits the synthesis and release of pro-inflammatory cytokines, including IL-1β, IL-6, IL-8, and TNF-α.
"highlight2" >*IL6↓,
"highlight2" >*IL8↑,
"highlight2" >*TNF-α↓,
"highlight2" >*NF-kB↓, inhibition of the nuclear factor κB (NF-κB)
"highlight2" >*BP↓, 15 or 30 mg of lycopene was associated with a significant reduction in systolic BP

1711- Lyco,    Nutritional Importance of Carotenoids and Their Effect on Liver Health: A Review
- Review, Var, NA
"highlight2" >ROS↑, exposure to high doses of carotenoids has a pro-oxidant effect
"highlight2" >Dose↓, lycopene, an intake of 5 to 7 mg per day was recommended for healthy people to maintain the circulating levels of this carotenoid, in order to combat oxidative stress and prevent chronic diseases
"highlight2" >Dose↑, higher concentrations of lycopene (35–75 mg/day) may be required when there is a disease, such as cancer and cardiovascular diseases.
"highlight2" >antiOx↑, main protective effect of lycopene is due to its antioxidant effect through the inactivation of ROS and the extinction of free radicals
"highlight2" >P450↓, significant decrease in cytochrome P450 2E1
"highlight2" >TNF-α↓, TNF-α, IL-1β, and IL-12) were also found
"highlight3" >IL1β↓,
"highlight2" >IL12↓,

3278- Lyco,    Anti-inflammatory effect of lycopene in SW480 human colorectal cancer cells
- in-vitro, Colon, SW480
"highlight2" >TNF-α↓, In cells treated with lycopene and LPS, the mRNA expression of TNF-α, IL-1β, IL-6, iNOS, and COX-2 were decreased significantly in a dose-dependent manner
"highlight3" >IL1β↓,
"highlight2" >IL6↓,
"highlight2" >iNOS↓,
"highlight2" >COX2↓,
"highlight2" >PGE2↓, The concentrations of PGE2 and NO decreased according to the lycopene concentration
"highlight2" >NO↓,
"highlight2" >NF-kB↓, The protein expressions of NF-κB and JNK were decreased significantly according to lycopene concertation
"highlight2" >JNK↓,
"highlight2" >Inflam↓, Lycopene was found to have anti-inflammatory effects in a rat model
"highlight2" >MPO↓, decreased myeloperoxidase (MPO) activity, as a marker of inflammation,

3264- Lyco,    Pharmacological potentials of lycopene against aging and aging‐related disorders: A review
- Review, Var, NA - Review, AD, NA - Review, Stroke, NA
"highlight2" >*antiOx↑, Anti‐oxidative mechanism of lycopene
"highlight2" >*ROS↓, Lycopene inhibits ROS generation and subsequent oxidative stress by inducing antioxidant enzymes (SOD, CAT, GSH, GSH‐Px, and GST) and limiting MDA level and lipid peroxidation (LPO).
"highlight2" >*SOD↑,
"highlight2" >*Catalase↑,
"highlight2" >*GSH↑,
"highlight2" >*GSTs↑,
"highlight2" >*MDA↓,
"highlight2" >*lipid-P↓,
"highlight2" >*NRF2↑, Lycopene also prevents ROS release by upregulating Nrf2‐mediated HO‐1 levels and inhibiting iNOS‐activated NO generation
"highlight2" >*HO-1↑,
"highlight2" >*iNOS↓,
"highlight2" >*NO↓,
"highlight2" >*TAC↑, upregulating total antioxidant capacity (TAC) and direct inhibition of 8‐OHdG, NOX4.
"highlight2" >*NOX4↓,
"highlight2" >*Inflam↓, Anti‐inflammatory mechanism of lycopene.
"highlight2" >*IL1↓, IL‐1, IL‐6, IL‐8, IL‐1β, and TNF‐α release.
"highlight2" >*IL6↓,
"highlight2" >*IL8↓,
"highlight3" >*IL1β↓,
"highlight2" >*TNF-α↓,
"highlight2" >*TLR2↓, prevents inflammation by inhibiting toll‐like receptors TLR2 and TLR4 and endothelial adhesion molecules VCAM1 and ICAM‐1.
"highlight2" >*TLR4↓,
"highlight2" >*VCAM-1↓,
"highlight2" >*ICAM-1↓,
"highlight2" >*STAT3↓, inhibiting STAT3, NF‐κB, ERK pathway, and IL‐6 and TNF‐α release.
"highlight2" >*NF-kB↓,
"highlight2" >*ERK↓,
"highlight2" >*BP↓, Another clinical study demonstrated that consumption of raw tomato (200 g/day) could prevent type 2 diabetes‐associated cardiovascular diseases by lowering systolic and diastolic blood pressure, upregulating ApoA1, and downregulating ApoB levels
"highlight2" >ROS↓, lycopene suppresses the metastasis of the SK‐HEP‐1 cell line by NOX‐4 mRNA expression inhibition and the reactive ROS intracellular activity inhibition
"highlight2" >PGE2↓, Lycopene is also used to treat colorectal cancer cells in humans, and the introduction of lycopene decreases the prostaglandin E2 and nitric oxide levels
"highlight2" >cardioP↑, Lycopene‐rich foods can be highly beneficial in preventing cardiovascular diseases as lycopene is a potential source of antioxidants
"highlight2" >*neuroP↑, beneficial role of lycopene on aging‐related neurodegenerative disorders, such as Alzheimer's disease and Parkinson's disease, has been confirmed in both experimental and clinical trials
"highlight2" >*creat↓, Several pre‐clinical studies reported that lycopene treatment significantly reduced serum urea and serum creatinine, as well as reversed various toxic chemical‐induced nephrotoxicity and oxidative damage by exhibiting excellent antioxidative properti
"highlight2" >*RenoP↑,
"highlight2" >*CRM↑, its potency in treating aging disorders and its role as a mimic of caloric restriction.


Showing Research Papers: 1 to 8 of 8

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 8

Pathway results for Effect on Cancer / Diseased Cells:


Redox & Oxidative Stress

antiOx↑, 1,   MPO↓, 1,   ROS↓, 2,   ROS↑, 2,   SOD↓, 1,  

Cell Death

Bax:Bcl2↑, 1,   Casp3↑, 1,   iNOS↓, 2,   JNK↓, 1,   survivin↓, 1,  

Migration

E-cadherin↑, 1,   MMP2↓, 1,   MMP7↓, 1,   MMP9↓, 1,   TIMP1↑, 1,   TIMP2↑, 1,   TumCA↓, 1,   TumCI↓, 1,   TumCMig↓, 1,   TumCP↓, 1,  

Angiogenesis & Vasculature

NO↓, 1,   VEGF↓, 1,  

Immune & Inflammatory Signaling

COX2↓, 3,   IL12↓, 1,   IL1β↓, 3,   IL6↓, 2,   Inflam↓, 2,   NF-kB↓, 2,   PGE2↓, 2,   TNF-α↓, 3,  

Drug Metabolism & Resistance

BioAv↝, 1,   ChemoSen↑, 1,   Dose↓, 1,   Dose↑, 1,   P450↓, 1,  

Clinical Biomarkers

IL6↓, 2,  

Functional Outcomes

AntiCan↑, 1,   cardioP↑, 1,   chemoP↑, 1,  
Total Targets: 39

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress

antiOx↑, 4,   ARE↑, 1,   Catalase↑, 2,   GPx↑, 2,   GSH↑, 2,   GSR↑, 1,   GSTs↓, 1,   GSTs↑, 1,   H2O2↓, 1,   HO-1↑, 3,   lipid-P↓, 2,   MDA↓, 1,   MPO↓, 1,   NOX4↓, 1,   NQO1↑, 1,   NRF2↑, 3,   ROS↓, 4,   SOD↑, 3,   TAC↑, 2,   VitC↑, 1,   VitE↑, 1,  

Core Metabolism/Glycolysis

CRM↑, 1,  

Cell Death

Akt↓, 1,   iNOS↓, 1,   MAPK↓, 1,  

Proliferation, Differentiation & Cell State

ERK↓, 1,   STAT3↓, 1,  

Migration

TGF-β1↑, 1,   VCAM-1↓, 1,  

Angiogenesis & Vasculature

NO↓, 2,  

Barriers & Transport

BBB↑, 2,  

Immune & Inflammatory Signaling

COX2↓, 2,   ICAM-1↓, 1,   IL1↓, 2,   IL10↑, 1,   IL12↓, 1,   IL1β↓, 5,   IL6↓, 4,   IL8↓, 1,   IL8↑, 1,   Inflam↓, 4,   NF-kB↓, 3,   TLR2↓, 1,   TLR4↓, 1,   TNF-α↓, 5,  

Synaptic & Neurotransmission

BDNF↑, 1,  

Drug Metabolism & Resistance

BioAv↓, 1,   BioAv↑, 3,   BioAv↝, 2,   Half-Life↑, 1,  

Clinical Biomarkers

BP↓, 2,   creat↓, 1,   IL6↓, 4,  

Functional Outcomes

cardioP↑, 2,   cognitive↑, 1,   memory↑, 1,   neuroP↑, 3,   radioP↑, 1,   RenoP↑, 1,  
Total Targets: 59

Scientific Paper Hit Count for: IL1β, interleukin-1 beta
8 Lycopene
1 5-fluorouracil
1 Chemotherapy
1 Cisplatin
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:119  Target#:978  State#:%  Dir#:%
wNotes=on sortOrder:rid,rpid

 

Home Page